Pap Smear Test in IndiaLBC · HPV DNA Co-Testing · Bethesda Classification · Colposcopy · Costs — The Complete Patient Guide
Everything You Need to Know About Cervical Screening — in Plain Language. Life-Protecting. 5-Minute Procedure.
⚡ Key Facts at a Glance — Pap Smear Test in India
India accounts for approximately 25% of the world's cervical cancer deaths — not because cervical cancer is incurable, but because it is overwhelmingly diagnosed at late stages. Yet cervical cancer is one of the most preventable cancers known to medicine.
The Pap smear detects the cell changes that occur over 10–15 years between initial HPV infection and the development of cancer — providing a wide, completely treatable window. Regular Pap smears reduce cervical cancer mortality by over 80% in populations where they are consistently used.
This guide covers every question a woman in India might have about the Pap smear — from what it is and whether it hurts, to how much it costs, what an abnormal result means, what LBC and HPV DNA testing add, and why women across Mumbai choose Shree Hospitals and Dr. Jay Mehta's team for this important but routinely neglected test.
Who Should Read This Guide?
Any woman aged 21–65 who has ever been sexually active; women who have received an abnormal Pap smear result and want to understand it; women comparing LBC vs conventional smear and HPV co-testing; women considering their first-ever smear; women post-LLETZ entering their surveillance programme; and women wanting to book at Shree Hospitals, Mumbai, India.
What Is a Pap Smear? How Is the Test Done?
A Pap smear collects cells from the surface of the cervix — the narrow, lower part of the uterus that opens into the vagina — and examines them under a microscope for precancerous changes. It specifically targets the transformation zone — the small area where inner glandular cells of the cervical canal meet the outer squamous cells of the external cervix. This junction is where HPV infection takes hold and where precancerous changes (CIN — Cervical Intraepithelial Neoplasia) develop.
Step-by-Step: What Happens During a Pap Smear
- 1Preparation: You will be asked to lie on the examination couch with your knees bent and apart. A disposable paper sheet provides privacy. The nurse or doctor will explain what is about to happen.
- 2Speculum insertion: A clean, smooth speculum is gently inserted into the vagina to open it slightly and expose the cervix. This is the step most women find most uncomfortable — a brief pressure or stretching sensation. At Shree Hospitals, speculums are warmed and the smallest appropriate size is always used.
- 3Cell collection: A soft sampling brush is gently rotated on the surface of the transformation zone for a few seconds, collecting cells. This produces a brief, mild scraping sensation — like a very light scratch. It should not be painful. For LBC, the brush is rinsed into a liquid-preservative vial.
- 4Sample processing: The LBC vial is sent to the Shree Hospitals in-house laboratory. Cells are processed to form a thin, clean layer on a glass slide and examined by a specialist pathologist under a microscope.
- 5Result reporting: Results are available within 3–7 working days. At Shree Hospitals, results are communicated directly to the patient and reviewed by Dr. Jay Mehta — with a clear explanation of what the result means and what, if anything, needs to happen next.
The entire procedure takes 5–7 minutes from entering the room to leaving. For the vast majority of women, it is less uncomfortable than anticipated.
Does a Pap Smear Hurt? What Does It Feel Like?
This is the question that stops many women from booking their smear — and the honest, evidence-based answer is: for most women, no, a Pap smear does not hurt. Women who have had their first smear consistently report that the experience was far less uncomfortable than they expected.
The most common description is: a brief uncomfortable pressure (from the speculum) followed by a momentary mild scraping sensation (from the brush). The brush sweep of the cervix is very brief — less than 5 seconds. The speculum is in place for less than 2 minutes in most cases.
Who Might Find It More Uncomfortable?
Post-menopausal women with vaginal atrophy: Topical vaginal oestrogen cream for 2–4 weeks before the smear appointment significantly improves comfort. Women with vaginismus: A slow, patient approach with the smallest speculum and full patient control. Women with anxiety: At Shree Hospitals, women who are anxious are never rushed. You are always in control and can stop at any time. If you have previously had an unpleasant smear experience — a rushed examination, inadequate privacy, feeling uninformed — please know that this does not have to be repeated at Shree Hospitals.
Pap Smear Technology — Conventional vs LBC vs Co-Test
Not all Pap smears are equal — the technology used profoundly affects accuracy and what additional information it can provide.
| Feature | Conventional Pap Smear (Glass Slide) | LBC (Liquid-Based Cytology) | LBC + HPV DNA Co-Test (Best Available) |
|---|---|---|---|
| Sample quality | Variable — clumping, blood, mucus can obscure cells | Excellent — clean, uniform cell layer with >98% adequate samples | Same as LBC — consistent quality |
| Inadequate sample rate | 8–10% — high rate; requires repeat smear | <1% — virtually eliminates inadequate results | <1% |
| Sensitivity for CIN 2+ | ~50–70% | ~80–90% | 95–99% — highest available |
| HPV testing from same sample? | NO — requires a separate collection | YES — residual sample can be used | YES — done simultaneously |
| Screening interval with negative result | 3 years | 3 years | 5 years — the longest safe interval |
| Cost in India (approx.) | ₹200–500 | ₹800–1,500 | ₹2,000–4,000 (co-test together) |
| Availability at Shree Hospitals | Not offered (superseded by LBC) | YES — In-house LBC processing | YES — In-house HPV DNA testing on same sample |
| Ideal for | Legacy hospitals / rural settings with basic equipment only | All modern urban centres — should be the standard for every woman | Preferred for women 30+; provides 5-year screening interval; best value test overall |
What Does an Abnormal Pap Smear Mean? The Bethesda Classification
An abnormal Pap smear does NOT mean you have cancer — and this is the most important thing to understand before you read your result. The Bethesda System describes a spectrum from completely normal (NILM), through minor changes that often clear on their own (ASCUS, LSIL), to significant precancerous changes (HSIL) that require treatment.
| Bethesda Result | Plain Language Meaning | What It Means and What Happens Next |
|---|---|---|
| NILM | ✓ NORMAL | The best possible result. No precancerous changes, no cancer cells, no HPV-related changes. Routine recall as per screening protocol (3 years if cytology only; 5 years if co-test negative). |
| ASCUS Atypical Squamous Cells of Undetermined Significance | MILD ABNORMALITY | Cells are slightly abnormal but not enough to classify as low-grade or high-grade. Very common — present in 3–5% of smears. In most women, reflects a transient HPV infection that will clear. Management: HPV reflex test from LBC vial (if HPV negative — return to routine screening; if HPV positive — colposcopy). |
| ASC-H Atypical Squamous Cells — Cannot Exclude High-Grade | INTERMEDIATE CONCERN | Like ASCUS but with features suggesting a high-grade lesion may be present. Requires immediate colposcopy regardless of HPV status — the clinical concern is too high to rely on HPV testing alone. |
| LSIL Low-Grade Squamous Intraepithelial Lesion | PRECANCEROUS — Low Grade (CIN 1) | Low-grade changes consistent with active HPV infection. Most (60%) regress spontaneously within 2 years. Referred for colposcopy. Management after colposcopy: active surveillance with repeat smear in 12 months, or LLETZ if persistent at 24 months. |
| HSIL High-Grade Squamous Intraepithelial Lesion | PRECANCEROUS — High Grade (CIN 2 or CIN 3) | High-grade precancerous change — the type that WILL progress to invasive cancer if left untreated. Requires urgent colposcopy. Treatment with LLETZ (Large Loop Excision of the Transformation Zone) is standard — outpatient, 15-minute procedure, local anaesthetic, >95% cure rate. |
| AGC Atypical Glandular Cells | MODERATE–HIGH CONCERN | Abnormality in the glandular cells (endocervical or endometrial origin). Carries a higher risk of significant underlying pathology than ASCUS. Requires: urgent colposcopy + endocervical sampling + endometrial biopsy. Dr. Jay Mehta reviews all AGC results personally at Shree Hospitals. |
| AIS Adenocarcinoma In Situ | VERY HIGH CONCERN | Pre-invasive glandular cancer of the cervical canal. Requires cone biopsy (not simple LLETZ) for complete assessment. Concurrent invasive cancer present in approximately 13% of cases. Hysterectomy recommended for women who have completed their family. |
| Suspicious for / Positive for Carcinoma | 🚨 URGENT | The smear has identified cells diagnostic of or strongly suspicious for invasive cancer. If a visible cervical lesion is present, biopsy must be taken immediately — do not wait for a smear result to arrange biopsy. Staging MRI and CT urgently. Urgent referral to Gynecologic Oncology at Shree Hospitals. |
| Inadequate / Unsatisfactory | REPEAT NEEDED | Insufficient cells for reliable analysis. Most commonly occurs with conventional smear (10% rate) — rarely with LBC (<1%). Repeat after 8–12 weeks. Inadequate smear rate at Shree Hospitals is <1% due to in-house LBC processing. |
Results Pathway — What Happens After Each Pap Smear Result
| Pap Smear Result | Standard Management Pathway |
|---|---|
| NILM + HPV Negative (Ideal — Normal co-test) | ✅ ROUTINE RECALL in 5 years. No further action. The most reassuring result — the 5-year interval reflects the very low risk of disease developing in this time. |
| NILM + HPV Positive (not 16/18) | ⚠️ REPEAT CO-TEST in 12 months. If still HPV positive at 12 months — refer for colposcopy. If HPV negative at 12 months — return to 5-year routine recall. |
| NILM + HPV 16 or 18 Positive | ⚠️ REFER FOR COLPOSCOPY within 4–8 weeks — even though cells look normal. HPV 16/18 carries high enough risk that direct colposcopy is safer than waiting for cytological abnormality to develop. |
| ASCUS + HPV Negative | ✅ LOW RISK. Repeat cytology in 3 years. HPV negative ASCUS is very unlikely to represent significant pathology. |
| ASCUS + HPV Positive | ⚠️ REFER FOR COLPOSCOPY within 4–8 weeks. HPV-positive ASCUS carries a meaningful risk of underlying CIN 2+ that colposcopy is needed to exclude. |
| LSIL (any HPV status) | ⚠️ REFER FOR COLPOSCOPY within 4–8 weeks. Colposcopy and biopsy determine the actual grade of lesion. Management after biopsy: CIN 1 → surveillance; CIN 2/3 → LLETZ. |
| ASC-H or HSIL | 🔴 URGENT COLPOSCOPY within 2–4 weeks. High-grade precancerous changes that require treatment. At Shree Hospitals: urgent same-visit or next-available-appointment colposcopy + LLETZ if confirmed CIN 2/3. |
| AGC (Atypical Glandular Cells) | 🔴 URGENT SPECIALIST EVALUATION within 2 weeks. Requires: colposcopy + endocervical curettage + endometrial biopsy. Dr. Jay Mehta reviews all AGC results personally at Shree Hospitals. |
| Suspicious for / Positive for Cancer | 🚨 EMERGENCY REFERRAL. Biopsy of visible lesion must be taken at the time of examination. Staging investigations (MRI, CT) arranged within days. Full oncological workup and treatment plan. |
LBC (Liquid-Based Cytology) — The Modern Standard of Pap Smear
LBC has replaced the conventional glass-slide Pap smear as the gold standard of cervical cytology in all modern gynaecology and oncology centres. The conventional Pap smear suffers from a significant limitation: cells are mixed with blood, mucus, and debris that can obscure abnormal cells — and up to 10% of samples are inadequate for analysis.
LBC addresses this by rinsing the sampling brush into a liquid preservative. All collected cells are transferred. In the laboratory, the sample is processed to produce a thin, uniform, clean layer of cells. The result: <1% inadequate sample rate, higher sensitivity for CIN 2+, and the residual liquid preserves the cellular DNA, allowing HPV DNA testing from the same sample.
In-House LBC Processing at Shree Hospitals
At Shree Hospitals, LBC samples are processed in-house at the pathology laboratory — not sent to an external laboratory. This provides: faster results (typically within 3–5 working days); direct quality supervision by the Gynecologic Oncology team; the ability to prioritise urgent samples; and results reviewed by Dr. Jay Mehta — not handed to the patient as an unexplained number on a report. Women booking a Pap smear at Shree Hospitals receive LBC as the standard of care.
HPV DNA Testing — What It Adds to Your Pap Smear
HPV (Human Papillomavirus) DNA testing detects the presence of high-risk HPV types in the cervical sample — the virus that directly causes cervical cancer. Combined with LBC cytology, it creates the most powerful cervical cancer screening combination currently available: the Co-Test.
| HPV Type | Risk Category | Clinical Significance and Action |
|---|---|---|
| HPV 16 | VERY HIGH RISK — Highest oncogenic potential | Responsible for approximately 50% of all cervical cancers worldwide. A positive HPV 16 result on co-testing triggers immediate colposcopy referral regardless of smear appearance — the risk of concurrent CIN 3 or cancer is too high to wait. |
| HPV 18 | HIGH RISK — Second most oncogenic | Responsible for approximately 15–20% of cervical cancers. More commonly associated with adenocarcinoma (glandular cancer) of the cervix. Like HPV 16, a positive HPV 18 test triggers immediate colposcopy. Together, HPV 16 and 18 cause approximately 70% of all cervical cancers. |
| HPV 31, 33, 45, 52, 58 | HIGH RISK — Significant but lower than 16/18 | The next most significant high-risk HPV types after 16 and 18. Account for an additional 15–20% of cervical cancers. All five are covered by the Gardasil 9 vaccine. A positive result for these types on co-testing triggers repeat co-testing in 12 months, or colposcopy if cytology is also abnormal. |
| HPV 6 and 11 | LOW RISK — Do NOT cause cancer | These two types are the cause of over 90% of genital warts. They do NOT cause cervical cancer. A positive HPV 6/11 test is not clinically significant for cancer screening purposes — cervical screening HPV tests only detect high-risk types. |
| HPV Not Detected | VERY REASSURING | In a co-test, HPV not detected combined with normal cytology (NILM) provides the strongest available reassurance against cervical cancer. The 5-year risk of CIN 3+ after a negative co-test is extremely low (<0.1%). This allows a safe 5-year screening interval. |
| Patient Group | Recommended Screening Protocol | Rationale and Key Points |
|---|---|---|
| Women aged 21–24 | Pap smear (cytology) alone every 3 years. HPV co-testing NOT recommended in this group. | The cervix naturally resolves most HPV infections in young women. HPV testing is not recommended under age 25 because false positives would cause unnecessary anxiety and colposcopy referrals. |
| Women aged 25–29 | Pap smear every 3 years OR HPV primary testing every 5 years. Co-testing optional. | HPV primary testing becomes appropriate from age 25. If using cytology alone — every 3 years. If using HPV test alone — every 5 years. Co-testing (most sensitive) — every 5 years. |
| Women aged 30–65 | LBC + HPV DNA Co-Test every 5 years — PREFERRED. Cytology alone every 3 years — acceptable. | The 30–65 age group is when cervical cancer risk peaks. Co-testing is the most sensitive and cost-effective strategy. A negative co-test (NILM + HPV negative) provides 5 years of very high reassurance. |
| Women over 65 | Screening can be discontinued if: last 3 consecutive cytology tests (or last 2 co-tests) are negative AND no history of CIN 2+ in last 20 years. | Women who have been consistently negative on screening do not require screening after 65. Women with a history of CIN 2+ should continue surveillance for at least 20 years after treatment. |
| HIV-positive women | Annual Pap smear regardless of age. Co-testing if available. | HIV-positive women are at 5–10 times higher risk of cervical cancer and CIN due to impaired immune clearance of HPV. Annual screening is the standard recommendation from the time of HIV diagnosis. |
| Post-hysterectomy | Routine cervical screening NOT needed IF hysterectomy was total (cervix removed) AND no prior history of CIN 2+ or cervical cancer. | After total hysterectomy with no prior history of high-grade cervical disease, the cervix has been removed and cancer risk from the cervix is essentially zero. |
| Post-HPV vaccination | Continue Pap smear screening as normal — vaccination does NOT replace screening. | HPV vaccination prevents infection with 70–90% of cancer-causing HPV types but not all. Vaccinated women still carry a residual risk from non-vaccine HPV types and must continue regular screening. |
Colposcopy — What It Is and How to Interpret the Findings
Colposcopy is the diagnostic examination that follows an abnormal Pap smear. It uses a colposcope — a large, lighted magnifying instrument that provides a ×10–40 magnified view of the cervix. The colposcope does not enter your body. At Shree Hospitals, colposcopy is performed by Dr. Jay Mehta — a full-time MCH Gynecologic Oncosurgeon.
What Happens During Colposcopy?
- 1Speculum insertion (as for the smear test). The colposcopist uses the colposcope to examine the cervix at ×10–40 magnification from outside the body.
- 2Acetic acid application — 3–5% dilution painted on the cervix using a cotton swab. Abnormal cells turn white (acetowhite areas) — these are the primary target of colposcopic assessment.
- 3Lugol's iodine (Schiller's test) may then be applied — normal cells stain dark mahogany brown; abnormal cells do not stain. This helps define the boundaries of abnormal areas.
- 4Biopsy — if abnormal areas are seen, a small punch biopsy (2–3mm tissue sample) is taken from the most abnormal area. This takes a fraction of a second and causes a brief, sharp sensation. Biopsy is sent to the pathology laboratory for histological diagnosis.
The whole procedure takes 15–20 minutes. Most women can drive home afterwards. Some mild spotting, cramping, and a dark vaginal discharge (from the iodine) for 24–48 hours is completely normal. At Shree Hospitals, same-session LLETZ (if biopsy shows CIN 2/3) is available — meaning diagnosis and treatment can happen in a single visit.
| Colposcopy Finding | Colposcopic Features Seen | Histological Grade | Management |
|---|---|---|---|
| Normal Colposcopy | Fully visible transformation zone; no acetowhite areas; no abnormal vascular patterns; Lugol's iodine staining uniform | CIN 0 — No dysplasia | Routine surveillance. If smear was LSIL — repeat Pap smear in 12 months. |
| Grade 1 (Minor) — Low-Grade CIN | Thin, faint acetowhite change with regular borders. Lugol's partial staining. Fine mosaic or fine punctation patterns. | CIN 1 — Low-grade dysplasia. Active HPV infection. | Active surveillance — repeat Pap smear at 12 months. LLETZ if persistent at 24 months or by patient preference. Most will spontaneously regress. |
| Grade 2 (Major) — High-Grade CIN | Dense, bright white acetowhite change with irregular borders. Coarse mosaic and/or coarse punctation. Opaque ('thick') acetowhite. | CIN 2 or CIN 3 — Moderate to severe dysplasia. | LLETZ (Large Loop Excision of the Transformation Zone) — standard outpatient treatment. Performed under local anaesthetic at Shree Hospitals. 15–20 minutes. Histology confirms grade and clear margins. |
| AIS Features (Glandular Lesion) | Colposcopy may appear normal or show subtle features — AIS often in the endocervical canal beyond direct vision. | AIS (Adenocarcinoma In Situ) — Pre-invasive glandular cancer. | Cone biopsy (not LLETZ alone) — requires adequate sampling of the endocervical canal. Hysterectomy recommended for women who have completed their family. |
| Atypical Blood Vessels | Irregular, bizarre-looking vessels — spiralling, corkscrew, hairpin shapes; branching stops abruptly; wide intercapillary distances. | Stage IA or IB Cervical Cancer — Early or established invasive cancer. | BIOPSY IMMEDIATELY. Referral to Gynecologic Oncology at Shree Hospitals urgently. Staging MRI and CT. Oncological treatment plan. |
Risk Factors for Abnormal Pap Smear and CIN
| Risk Factor | Risk Level | What You Need to Know |
|---|---|---|
| Persistent high-risk HPV infection (especially HPV 16 and 18) | VERY HIGH — Causal | HPV is the cause of virtually all abnormal Pap smear results and cervical cancers. Without persistent high-risk HPV infection, cervical cancer cannot develop. HPV vaccination before first sexual exposure prevents 70–90% of the HPV infections that cause cervical cancer. |
| Never having had a Pap smear | VERY HIGH — Most important preventable risk | Women who have never been screened are at dramatically higher risk of having undetected CIN 2/3 or even invasive cervical cancer. A first-ever Pap smear at any age (up to 65) provides meaningful protection. |
| Smoking | MODERATE — 2x increased CIN and cervical cancer risk | Tobacco carcinogens found in cervical mucus impair local cervical immunity and increase the risk of persistent HPV infection progressing to CIN. Smokers have a higher rate of abnormal smears. |
| HIV infection / Immunosuppression | HIGH — 5–10x increased risk | Impaired immune function allows HPV infections to persist and cause CIN. HIV-positive women need annual Pap smears. Other immunosuppressed groups (transplant recipients, long-term steroids) also warrant more frequent screening. |
| Previous CIN or abnormal smear | MODERATE — Ongoing surveillance needed | Women with a history of CIN 2+ require 10-year surveillance smears after LLETZ treatment. Recurrence of CIN after treatment occurs in approximately 5–10% of cases and requires prompt re-treatment. |
| HPV Vaccination (Gardasil 9 / Cervarix / CERVAVAC) | HIGHLY PROTECTIVE — 70–90% cancer prevention | Vaccination before HPV exposure (ages 9–14) reduces risk of CIN 2+ by 70–90%. Even post-vaccination women must continue Pap smear screening — the vaccine does not cover all high-risk HPV types. |
| Regular Pap smear screening | HIGHLY PROTECTIVE — 80%+ mortality reduction | Regular screening is the most powerful single intervention for reducing cervical cancer mortality. Even a single Pap smear in a lifetime reduces mortality by >25%. Regular 3–5 yearly screening reduces mortality by >80%. |
Cost of Pap Smear and Related Procedures in India (2024)
| Test / Procedure | Approximate Cost (₹ — 2024) | Availability | Important Notes |
|---|---|---|---|
| Conventional Pap Smear (Glass Slide — Being phased out) | ₹200–500 | Government hospitals, basic pathology labs, tier-2 city labs | Oldest technique. Higher inadequate sample rate (~10%). Less sensitive. Acceptable where LBC is not available. Not recommended as first choice. |
| LBC Pap Smear (Liquid-Based Cytology) | ₹800–1,500 | Most private labs in Mumbai and metro cities. In-house at Shree Hospitals. | Modern gold standard cytology. Clean sample, <1% inadequate, retains sample for HPV testing. The test every woman should request by name. |
| HPV DNA Test (Standalone) | ₹1,500–3,000 | Private labs in major cities. In-house at Shree Hospitals. | Tests for high-risk HPV types. Most informative when combined with LBC. Standalone HPV test without cytology is used for primary HPV screening. |
| LBC + HPV DNA Co-Test (Recommended for women 30+) | ₹2,000–4,500 | Premium private labs, Gynecologic Oncology centres. In-house at Shree Hospitals. | The most sensitive and cost-effective cervical cancer screening combination. Allows 5-year intervals. Best value overall — the 5-year safety window makes it more cost-effective per year than annual conventional smears. |
| Colposcopy (Examination only) | ₹2,000–5,000 | Private gynaecology practices, specialist centres | Diagnostic procedure after an abnormal smear. At Shree Hospitals: performed by Dr. Jay Mehta (MCH Gynec Oncosurgeon) — not a junior doctor or general gynaecologist. |
| Colposcopy + Directed Biopsy | ₹3,000–7,000 | Specialist centres with proper histology processing | Colposcopy with tissue sample for laboratory analysis. Histopathology report typically 5–10 working days. |
| LLETZ Treatment (For CIN 2/3 — curative procedure) | ₹15,000–35,000 | Gynaecology / Gynec Oncology centres with outpatient procedure rooms | Definitive outpatient treatment for high-grade CIN. Local anaesthetic. 15–20 minutes. At Shree Hospitals: performed by Dr. Jay Mehta with full histology processing in-house. |
| Cone Biopsy (For AIS / Persistent CIN 3) | ₹20,000–50,000 | Specialist surgical centres | Requires operating theatre and anaesthesia. For AIS or where LLETZ is insufficient. At Shree Hospitals: available with full anaesthesia and day-case surgical infrastructure. |
Cost Perspective — LBC + HPV Co-Test Once Every 5 Years
The cost of a co-test once every 5 years averages ₹500–900 per year — the most cost-effective cervical cancer prevention investment available. At Shree Hospitals, current pricing is always communicated transparently before the test — please call +91-9920914115 for current pricing at the time of your appointment.
Why Women Across Mumbai Choose Shree Hospitals for Their Pap Smear
A Pap smear is a routine, simple test. Surely any gynaecology clinic can perform it? In technical terms — yes. But in terms of the quality of the test, the reliability of the result, the expertise available to interpret it, and the completeness of the care pathway that follows an abnormal result — there are significant differences between centres. And for a test whose purpose is to protect a woman from cervical cancer, these differences matter.
| Advantage at Shree Hospitals | What This Means for You — Why It Matters |
|---|---|
| Full-Time MCH Gynecologic Oncosurgeon — Dr. Jay Mehta & Team | At most gynaecology practices and diagnostic centres in Mumbai, a Pap smear is performed by a nurse or junior doctor and reported by a general pathologist. At Shree Hospitals, every Pap smear is performed under the oversight of Dr. Jay Mehta — a full-time MCH Gynecologic Oncosurgeon. The entire care pathway from smear to colposcopy to LLETZ to cancer surgery, if ever needed, happens within the same dedicated department. No referral chain. No delays. No loss of context. |
| In-House LBC Processing — No External Lab Delays or Quality Gaps | Shree Hospitals processes LBC samples in-house at its pathology department. No sample transport to an external laboratory (which can affect sample quality). Results are available faster. Quality is directly supervised by the Gynecologic Oncology team. Most diagnostic centres in Mumbai send LBC samples to an external laboratory — often with a 48–72-hour turnaround. At Shree Hospitals, in-house processing produces faster results, tighter quality control, and the ability to immediately repeat a sample if needed. |
| In-House HPV DNA Testing — Complete Co-Test Under One Roof | Shree Hospitals performs HPV DNA testing in-house — using the residual LBC sample. A truly simultaneous co-test: smear + HPV from the same sample, processed in the same facility, reported together. No additional patient visit for a separate HPV test. And HPV genotyping that specifically identifies HPV 16 and 18 (which trigger immediate colposcopy) from other high-risk types (which allow a 12-month surveillance interval). |
| Dedicated Department for Gynecologic Oncosurgery — Complete Care Pathway in One Place | Colposcopy is performed by a specialist, not a general gynaecologist. LLETZ procedures are performed in a dedicated procedure room with appropriate equipment and pathology processing. Cone biopsy and cancer surgery, when ever needed, happen within the same department with a consistent surgical team. Follow-up after treatment is managed by the same specialist who performed the procedure. No referral delays. No repeated history-taking. |
| Cost Transparency and Ethics — No Upselling, No Unnecessary Tests | At Shree Hospitals, pricing is transparent and communicated before the procedure. The decision about which test to perform (LBC alone vs. co-test) is based on the woman's age, risk profile, and clinical indication — not on revenue considerations. A woman who comes for a routine LBC smear is not upsold unnecessary tests. A woman who needs an urgent colposcopy because her smear shows HSIL is not told to wait 6 weeks — she is seen urgently. |
| Compassionate, Culturally Sensitive Care — Breaking the Barrier of Embarrassment | Female nurses are present throughout the procedure. The consultation room and examination area are private and fully curtained. The clinical language used is respectful, non-judgemental, and in the patient's preferred language (English, Hindi, Marathi). Patients are given full information about exactly what the procedure involves before it begins. Breaking the barrier of embarrassment that prevents Indian women from getting life-saving cervical screening is a mission the Shree Hospitals team takes seriously. |
A Commitment to Women's Health in Mumbai and Beyond
Dr. Jay Mehta and the Gynecologic Oncology team at Shree Hospitals believe that the Pap smear should be as normal and routine a part of every Indian woman's healthcare as a blood pressure check. The cultural and social barriers that prevent Indian women from seeking cervical screening are real — and they are the primary reason India has such a disproportionate cervical cancer burden.
Our commitment at Shree Hospitals is to make cervical screening accessible, affordable, technically excellent, and psychologically comfortable for every woman who comes through our doors — from a 21-year-old having her first smear, to a 65-year-old finally getting her first-ever test, to a post-LLETZ patient entering her 10-year surveillance programme.
Frequently Asked Questions — Pap Smear Test in India
What exactly is a Pap smear?
A Pap smear detects abnormal cells on the cervix that may, if left untreated, progress to cancer over 10–15 years. When these precancerous changes (CIN — Cervical Intraepithelial Neoplasia) are detected and treated early, cervical cancer is prevented entirely. This is the power of the Pap smear.
Does a Pap smear hurt?
Post-menopausal women with atrophic vaginal walls may find the procedure more uncomfortable — topical vaginal oestrogen cream used for a few weeks before the appointment can significantly help. Women with vaginismus are managed with a slow, patient approach using the smallest speculum. At Shree Hospitals, every woman is fully informed about the procedure before it begins, the clinical team is trained to perform smears gently and respectfully, and you can stop at any time.
What does an abnormal Pap smear mean?
An abnormal smear is almost always the beginning of a curable story — not the end. Only the rarest result — 'Suspicious for carcinoma' — indicates actual cancer, and even early-stage cervical cancer is highly curable. The Bethesda System provides a precise spectrum from completely normal through minor changes that often clear on their own to significant precancerous changes requiring treatment, to the rare finding of actual cancer cells.
How much does a Pap smear cost in India?
The cost of a co-test once every 5 years averages ₹500–900 per year — the most cost-effective cervical cancer prevention investment available. By comparison, annual conventional smears at ₹300 each = ₹300 per year but provide less reassurance, less accuracy, and no HPV information. The 5-year safety window that a negative co-test provides makes it significantly more cost-effective than annual conventional smears on a per-year basis.
What is LBC (Liquid-Based Cytology) and why is it better?
LBC slides are also amenable to automated reading and digital storage. At Shree Hospitals, LBC is the standard of care — in-house processing ensures quality control and fast turnaround. Women booking a Pap smear at Shree Hospitals receive LBC as the standard, not as an additional upgrade or extra cost.
What is HPV DNA testing and should I have it alongside my Pap smear?
For women under 25: HPV testing alone is generally not recommended. For women 25–29: HPV testing is appropriate as co-testing or primary HPV testing. For women 30–65: Co-testing is the recommended standard. At Shree Hospitals, in-house HPV DNA testing with genotyping (identifying HPV 16 and 18 separately from other high-risk types) is available as part of the co-test package — determining whether immediate colposcopy or 12-month repeat is the appropriate next step.
I've been told I need a colposcopy. What should I expect?
Some mild spotting, cramping, and dark vaginal discharge (from the iodine) for 24–48 hours is completely normal. At Shree Hospitals, colposcopy is performed by Dr. Jay Mehta — a full-time MCH Gynecologic Oncosurgeon. Same-session LLETZ (if biopsy shows CIN 2/3) is available — meaning diagnosis and treatment can happen in a single visit, avoiding a second procedure appointment.
I had LLETZ for CIN 3. Am I cured? Do I need follow-up?
Recurrence occurs in approximately 5–10% of women after LLETZ — and is typically treatable if detected promptly. The LLETZ specimen must be checked to confirm clear margins (no CIN at the cut edge) — if margins are involved, repeat LLETZ or cone biopsy is needed. At Shree Hospitals, all LLETZ patients are enrolled in a structured 10-year surveillance programme with Dr. Mehta's team.
Can I have a Pap smear if I am pregnant?
Treatment for CIN (LLETZ or cone biopsy) is generally deferred until after delivery in most cases — because CIN is not cancer and the small risk of the procedure to the pregnancy outweighs the benefit of immediate treatment. However, if the smear suggests invasive cancer, immediate specialist evaluation is essential regardless of gestational age. If you are pregnant and your Pap smear is overdue — please have it done. At Shree Hospitals, smears during pregnancy are performed with extra care and gentleness by Dr. Mehta's team.
I am over 60 and have never had a Pap smear. Is it too late?
For post-menopausal women, topical vaginal oestrogen cream used for a few weeks before the smear appointment can significantly reduce the discomfort of the speculum examination by restoring vaginal moisture and elasticity. Please call +91-9920914115 to book your Pap smear at Shree Hospitals. One life-protecting test — it is never too late to have it.
My Pap smear result says 'AGC' (Atypical Glandular Cells). What does this mean?
The recommended response to AGC is: urgent colposcopy; endocervical curettage (sampling the inside of the cervical canal); and endometrial biopsy if the woman is over 35 or has any endometrial risk factors. AGC results are reviewed personally by Dr. Jay Mehta at Shree Hospitals — because this result requires the level of expertise that only a specialist Gynecologic Oncosurgeon can provide. Please do not wait for your next routine appointment if your result shows AGC — call Shree Hospitals at +91-9920914115 immediately.
I am embarrassed to have a Pap smear. How can I overcome this?
You will be fully informed before anything happens — the nurse will explain each step before it occurs. If at any time you want to pause or stop, you can. The procedure takes 2–3 minutes. The discomfort is brief. The protection it provides lasts 3–5 years. Consider that the embarrassment of this 2-minute procedure is significantly smaller than the consequences of a cervical cancer diagnosis that a smear could have prevented. At Shree Hospitals, breaking the barrier of embarrassment that prevents Indian women from getting life-saving cervical screening is a mission the team takes seriously.
🚨 You Need a Pap Smear Now — Do Not Wait Another Month
Any of the following means you should book your Pap smear today:
- You have NEVER had a Pap smear — regardless of your age, if you have ever been sexually active, you are overdue
- Your last Pap smear was more than 3 years ago (cytology-only) or 5 years ago (co-test) — you are overdue for repeat screening
- You have been told you have an abnormal Pap smear and have NOT yet had a follow-up colposcopy arranged
- You are experiencing post-coital bleeding (bleeding after sex) — this is a warning symptom of cervical cancer that requires urgent evaluation
- You have unusual vaginal discharge that has not resolved with standard treatment for infection
- You have a family history of cervical cancer or have been told you had an abnormal smear years ago without completing follow-up
- You are HIV-positive and your last Pap smear was more than 12 months ago — HIV-positive women need annual smears
- You are on tamoxifen (for breast cancer) and have not had a recent Pap smear — tamoxifen increases endometrial cancer risk
Book Your Pap Smear — Today
Cervical cancer is preventable. The Pap smear is the tool that prevents it. At Shree Hospitals, the Pap smear is performed by a dedicated Gynecologic Oncology team — with in-house LBC processing, in-house HPV DNA testing, and a full-time specialist available to manage every result. Whether you are booking your first-ever Pap smear, coming for a repeat screening, or seeking a second opinion on an abnormal result — Shree Hospitals provides the full spectrum of cervical screening and management in a single, dedicated, compassionate department.
✅ In-house LBC Processing ✅ In-house HPV DNA Test ✅ Full-time MCH Gynec Oncosurgeon ✅ Online Consultation Available
A Pap smear takes 5 minutes. It could save your life. Book today.
© Department of Gynecologic Oncology, Shree Hospitals, Mumbai, India. All rights reserved. Content may not be reproduced without written permission. | Primary keyword: pap smear test India | Secondary: LBC test India, HPV DNA test India, cervical screening India, colposcopy India | LSI Location: pap smear cost India, gynaecological oncologist Mumbai India
